Valneva to release Q1 2026 financial results on May 13 with a live webcast update.

Valneva SE, a specialty vaccine company, announced it will report its first quarter 2026 consolidated financial results on May 13, 2026. The company will host a live webcast at 3 p.m. CET/9 a.m. ET to discuss the results and provide a business update, accessible on its website. Valneva focuses on developing vaccines for infectious diseases, including a Lyme disease vaccine candidate partnered with Pfizer. This update is important for investors tracking the company's progress and vaccine pipeline development.